Inhibitor Therapeutics, Inc. (INTI) insider trading.
In Q3 2026, insiders at Inhibitor Therapeutics, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-08-04
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| MCNULTY JAMES A / Black Robe Capital LLC | Officer, TenPercentOwner · Chief Financial Officer | 1 | 0 | 0 |
| Odonnell Francis E Jr | Director, Officer, TenPercentOwner · Chief Executive Officer | 1 | 0 | 0 |
| Sears Samuel P Jr | Director | 1 | 0 | 0 |
| Yanez Michelle | Director | 1 | 0 | 0 |
| Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 / OSMAN RONALD E | TenPercentOwner, Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | MCNULTY JAMES A / Black Robe Capital LLC | G (D) | 3,200,000 | $0 | 19,901,057 | Form 4 |
| 2026-05-04 | Odonnell Francis E Jr | A (A) | 50,000 | $0 | 150,000 | Form 4 |
| 2026-05-04 | Sears Samuel P Jr | A (A) | 50,000 | $0 | 1,229,543 | Form 4 |
| 2026-05-04 | Yanez Michelle | A (A) | 50,000 | $0 | 1,221,271 | Form 4 |
| 2026-05-04 | Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 / OSMAN RONALD E | A (A) | 50,000 | $0 | 23,614,985 | Form 4 |
Transaction codes in this quarter
Get INTI insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1042418&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · INTI company page · Inhibitor Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Inhibitor Therapeutics, Inc. (INTI)?
In Q3 2026, insiders at Inhibitor Therapeutics, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Inhibitor Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/inti.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.